Page results
-
This page has been written to answer some common questions about Tofersen treatment for patients, as well as their caregivers and families.
-
This service is unique in the UK, offering an adolescent rheumatology service that provides diagnostic and therapeutic advice to patients with any rheumatic diseases that occur in adolescence.
-
Periodontology is the management of patients with disorders of the gums and the supporting structures including teeth.
-
Restoritive dentistry services include periodontology, endodontics and orthodontics
-
Our Proton Beam Therapy (PBT) department can treat up to 650 NHS patients per year from across the south of the UK when we are at full capacity. We provide treatment for a wide range of child and teenage cancers and complex adult cancers.
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
File results
-
FOI/2023/0800 - Bank staff hire time/ recruitment/ mandatory training
-
FOI/2023/0769 - Patients with Inflammatory Bowel Disease/ Small Intestinal Bacterial Overgrowth (SIBO)
-
FOI/2023/0761 - Trust EPR system/ clinical data repository
-
FOI/2023/0735 - Endoscopy/ cystoscopy surveillance list
-
FOI/2023/0732 - Trust staff from EU 2016 to 2023
-
FOI/2023/0717 - Stolen or lost patient property
-
FOI/2023/0716 - Agency use across nursing and doctors/ expenditure 2022/23
-
FOI/2023/0606 - Carbon emissions 2019/20 to 2022/23
-
FOI/2023/0568 - Adverse reactions to the Astra Zeneca Covid vaccine
-
FOI/2023/0603 - Treatment of dermatological conditions